Literaturnachweis - Detailanzeige
Autor/inn/en | Ollendick, Thomas; Muskett, Ashley; Radtke, Sarah R.; Smith, Isaac |
---|---|
Titel | Adaptation of One-Session Treatment for Specific Phobias for Children with Autism Spectrum Disorder Using a Non-Concurrent Multiple Baseline Design: A Preliminary Investigation |
Quelle | In: Journal of Autism and Developmental Disorders, 51 (2021) 4, S.1015-1027 (13 Seiten)
PDF als Volltext |
Sprache | englisch |
Dokumenttyp | gedruckt; online; Zeitschriftenaufsatz |
ISSN | 0162-3257 |
DOI | 10.1007/s10803-020-04582-5 |
Schlagwörter | Anxiety Disorders; Autism; Pervasive Developmental Disorders; Program Effectiveness; Intervention; Parent Participation; Visual Aids; Telecommunications; Fear; Severity (of Disability); Behavior Modification |
Abstract | Anxiety disorders are among the most common co-occurring disorders for individuals with ASD. Several adaptations to cognitive behavioral approaches have been proposed for this population (Moree & Davis, 2010). The current study examined feasibility and preliminary efficacy of an ASD-specific adaptation of one-session treatment (OST) for specific phobia (SP). Standard OST consists of one 3-h session followed by four weekly phone calls. Modifications for ASD included increased parental involvement, use of visual aids, and inclusion of four 1-h booster sessions in place of the four weekly phone calls. Visual inspection and Friedman tests revealed significant reductions in fear ratings and phobia severity from pre- to post-treatment and follow-up assessments. Modest changes were observed in behavioral avoidance. These findings provide initial evidence that this treatment merits further study. (As Provided). |
Anmerkungen | Springer. Available from: Springer Nature. One New York Plaza, Suite 4600, New York, NY 10004. Tel: 800-777-4643; Tel: 212-460-1500; Fax: 212-460-1700; e-mail: customerservice@springernature.com; Web site: https://link.springer.com/ |
Erfasst von | ERIC (Education Resources Information Center), Washington, DC |
Update | 2024/1/01 |